Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 4,539 shares at $1.99 ($9K) on 2022-12-21, disclosed to the SEC on 2022-12-22.
Scheduled sale ($9k) by Chief Development & Regulatory under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $188K | — | Filing → |